FARN — Faron Pharmaceuticals Oy Balance Sheet
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall CapMomentum Trap
- £179.06m
- £184.52m
Annual balance sheet for Faron Pharmaceuticals Oy, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 4.07 | 7.06 | 4.11 | 6.85 | 6.99 |
| Net Total Receivables | 0.945 | 1.25 | 1.27 | 1.42 | 0.905 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 6.83 | 9.2 | 7.37 | 12 | 9.73 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.017 | 0.399 | 0.375 | 0.207 | 0.327 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 8 | 10.2 | 8.37 | 13.2 | 11.3 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5.75 | 6.08 | 6.5 | 7.18 | 10.5 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 7.63 | 8.6 | 10.2 | 10.3 | 22.7 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 0.369 | 1.61 | -1.85 | 2.92 | -11.5 |
| Total Liabilities & Shareholders' Equity | 8 | 10.2 | 8.37 | 13.2 | 11.3 |
| Total Common Shares Outstanding |